Back to top

Belviq XR

Generic drug


  • (07/15/2016)

    adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:

    • 30 kg/m2 or greater (obese) or

    • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition, (e.g., hypertension, dyslipidemia, type 2 diabetes)

    Limitations of Use:

    • The safety and efficacy of coadministration with other products for weight loss have not been established

    • The effect of BELVIQ XR on cardiovascular morbidity and mortality has not been established.